Literature DB >> 22050529

Sustained interaction: the new normal for stem cell repositories?

Rosario Isasi1, Bartha M Knoppers, Geoffrey Lomax.   

Abstract

Stem cell repositories, similar to many areas in human scientific research, must balance the interests of the individuals who donate their time and samples to science with the interests of scientific progress. This article seeks to explore how sustained interaction with stem cell donors can advance key donor interests (autonomy and privacy) while also increasing the scientific utility of stem cell lines. The ability to trace stem cell lines to their respective donors - underpinned by robust informed consent - enables donors to gain access to information regarding research outcomes and the uses of their biological samples, while also supporting basic and clinical research by providing a means for quality and safety controls. Measures to recontact donors and also to enable donors to withdraw from research should be well designed to ensure donors' preferences are respected while mitigating negative consequences resulting from limited data availability or compromised sample quality. To guarantee the integrity of research while respecting donors' autonomy and preferences, stem cell repositories require a prospective approach to informed consent.

Entities:  

Mesh:

Year:  2011        PMID: 22050529     DOI: 10.2217/rme.11.93

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  7 in total

1.  The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider.

Authors:  Geoffrey P Lomax; Sara Chandros Hull; Justin Lowenthal; Mahendra Rao; Rosario Isasi
Journal:  Stem Cells Transl Med       Date:  2013-08-29       Impact factor: 6.940

Review 2.  Great expectations: autism spectrum disorder and induced pluripotent stem cell technologies.

Authors:  Emily Yang Liu; Christopher Thomas Scott
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

3.  Broad versus blanket consent for research with human biological samples.

Authors:  David Wendler
Journal:  Hastings Cent Rep       Date:  2013 Sep-Oct       Impact factor: 2.683

4.  Developing cellular therapies for retinal degenerative diseases.

Authors:  Kapil Bharti; Mahendra Rao; Sara Chandros Hull; David Stroncek; Brian P Brooks; Ellen Feigal; Jan C van Meurs; Christene A Huang; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-26       Impact factor: 4.799

5.  Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.

Authors:  Justin Lowenthal; Scott Lipnick; Mahendra Rao; Sara Chandros Hull
Journal:  Stem Cells Transl Med       Date:  2012-05-08       Impact factor: 6.940

6.  A short report of Biosafety and Biobanking: current understanding and knowledge gaps.

Authors:  Julie Roux; Maissa Zeghidi; Stephanie Villar; Zisis Kozlakidis
Journal:  Biosaf Health       Date:  2021-06-19

7.  The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.

Authors:  Michael Morrison; Jessica Bell; Carol George; Shawn Harmon; Megan Munsie; Jane Kaye
Journal:  Regen Med       Date:  2017-10-04       Impact factor: 3.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.